Original languageEnglish
Pages (from-to)1213-1214
Number of pages2
JournalBritish Journal of Clinical Pharmacology
Volume85
Issue number6
DOIs
Publication statusPublished - 1 Jun 2019

Cite this

@article{0a51241b8ca4444788807e7e7bccc9c8,
title = "Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?",
keywords = "cytidine deaminase, gemcitabine, therapeutic drug monitoring",
author = "Peters, {Godefridus J.} and Elisa Giovannetti and Honeywell, {Richard J.} and Joseph Ciccolini",
year = "2019",
month = "6",
day = "1",
doi = "10.1111/bcp.13921",
language = "English",
volume = "85",
pages = "1213--1214",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "6",

}

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response? / Peters, Godefridus J.; Giovannetti, Elisa; Honeywell, Richard J.; Ciccolini, Joseph.

In: British Journal of Clinical Pharmacology, Vol. 85, No. 6, 01.06.2019, p. 1213-1214.

Research output: Contribution to journalComment/Letter to the editorAcademic

TY - JOUR

T1 - Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

AU - Peters, Godefridus J.

AU - Giovannetti, Elisa

AU - Honeywell, Richard J.

AU - Ciccolini, Joseph

PY - 2019/6/1

Y1 - 2019/6/1

KW - cytidine deaminase

KW - gemcitabine

KW - therapeutic drug monitoring

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065098905&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30866103

U2 - 10.1111/bcp.13921

DO - 10.1111/bcp.13921

M3 - Comment/Letter to the editor

VL - 85

SP - 1213

EP - 1214

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 6

ER -